DE69007968D1 - Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben. - Google Patents

Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben.

Info

Publication number
DE69007968D1
DE69007968D1 DE90902270T DE69007968T DE69007968D1 DE 69007968 D1 DE69007968 D1 DE 69007968D1 DE 90902270 T DE90902270 T DE 90902270T DE 69007968 T DE69007968 T DE 69007968T DE 69007968 D1 DE69007968 D1 DE 69007968D1
Authority
DE
Germany
Prior art keywords
oligonucleotide
branching
introduction
derivatives
allow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90902270T
Other languages
English (en)
Other versions
DE69007968T2 (de
Inventor
Robert Teoule
Andre Roget
Herve Bazin
Sylvie Sauvaigo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Application granted granted Critical
Publication of DE69007968D1 publication Critical patent/DE69007968D1/de
Publication of DE69007968T2 publication Critical patent/DE69007968T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
DE69007968T 1989-01-20 1990-01-19 Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben. Expired - Fee Related DE69007968T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8900655A FR2642074B1 (fr) 1989-01-20 1989-01-20 Derives de molecules polyhydroxylees permettant l'introduction d'au moins une ramification dans un oligonucleotide
PCT/FR1990/000043 WO1990008156A1 (fr) 1989-01-20 1990-01-19 Derives de molecules polyhydroxylees permettant l'introduction d'au moins une ramification dans un oligonucleotide

Publications (2)

Publication Number Publication Date
DE69007968D1 true DE69007968D1 (de) 1994-05-11
DE69007968T2 DE69007968T2 (de) 1994-10-20

Family

ID=9377902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69007968T Expired - Fee Related DE69007968T2 (de) 1989-01-20 1990-01-19 Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben.

Country Status (4)

Country Link
EP (1) EP0451213B1 (de)
DE (1) DE69007968T2 (de)
FR (1) FR2642074B1 (de)
WO (1) WO1990008156A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190981T1 (de) * 1989-10-24 2000-04-15 Isis Pharmaceuticals Inc 2'-modifizierte nukleotide
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5623070A (en) 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
NZ239250A (en) * 1990-08-09 1993-12-23 Genta Inc Chirally pure non-nucleotide reagents for use in preparing
US5965722A (en) 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US6495676B1 (en) * 1993-04-13 2002-12-17 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
WO1994024120A1 (en) * 1993-04-13 1994-10-27 Naxcor Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
US6277570B1 (en) 1993-04-13 2001-08-21 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
US5767259A (en) 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
EP0827501A4 (de) * 1995-03-09 1998-06-10 Naxcor Nichtnukleosidische cumarinderivate als polynukleotidevernetzer
CA2781519A1 (en) 2009-09-16 2011-03-24 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
WO2012085113A1 (en) 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Binding agent
CN103384825B (zh) 2010-12-23 2017-05-24 霍夫曼-拉罗奇有限公司 通过二价结合剂检测经翻译后修饰的多肽
SG11201402826YA (en) 2011-12-22 2014-12-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
KR20140127854A (ko) 2012-02-10 2014-11-04 제넨테크, 인크. 단일-쇄 항체 및 다른 이종다량체
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
RU2639287C2 (ru) 2012-06-27 2017-12-20 Ф. Хоффманн-Ля Рош Аг Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
WO2014001325A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616003A (en) * 1984-10-26 1986-10-07 Warner-Lambert Company N6 -dihydroxypropyladenosines
US4828979A (en) * 1984-11-08 1989-05-09 Life Technologies, Inc. Nucleotide analogs for nucleic acid labeling and detection
JPH0723393B2 (ja) * 1985-05-15 1995-03-15 アモコ・コーポレーション シチジン同族体
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
JP2828642B2 (ja) * 1987-06-24 1998-11-25 ハワード フローレイ インスティテュト オブ イクスペリメンタル フィジオロジー アンド メディシン ヌクレオシド誘導体

Also Published As

Publication number Publication date
FR2642074B1 (fr) 1994-04-29
FR2642074A1 (fr) 1990-07-27
WO1990008156A1 (fr) 1990-07-26
EP0451213A1 (de) 1991-10-16
DE69007968T2 (de) 1994-10-20
EP0451213B1 (de) 1994-04-06

Similar Documents

Publication Publication Date Title
DE69007968D1 (de) Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben.
FI914329A0 (fi) Bubblande, brandhaemmande belaeggnings- material.
DE69001007D1 (de) Kosmetische mittel zur braeunung.
FI915052A0 (fi) Hartsbehandlade, flytande roekningskompositioner.
DE59003387D1 (de) Stauchfalzwerk.
FI913317A0 (fi) Foerfarande foer framstaellning av trae-plast-agglomerat, samt anvaendning daerav.
FI901508A0 (fi) Maskin foer automatisk applicering av en elastisk taetning, saerskilt foer en glasruta eller en tillslutningslist.
FI895678A (fi) Faestanordning foer faestning av skivor, saerskilt ljusreklamskivor.
DE59008409D1 (de) Organosilylalkylaromaten.
ATE103928T1 (de) Derivate von polyhydroxylierten molekuelen, welche die einfuehrung von mindestens einer verzweigung in ein oligonukleotid erlauben.
DE69016857D1 (de) Verfahren zur Herstellung von NiNi-Diakyl- 1,8-Naphthalendiamin.
IT8119758A0 (it) Derivati 2'-deossi-3',5'-di-o-alchilcarbonil-5-fluorouri dinici processo per la loro preparazione e agenti antitumorali che contengono i detti derivati.
FI915335A0 (fi) Transmissionssystem, saerskilt kulledstransmissionssystem.
ATE121400T1 (de) Pyridyl-methylenamino-1,2,4-triazinone.
FI903792A0 (fi) Nickel-kopparskaerstenkonverter, i vilken anvaends kvaeveanrikad blaestring.
FI903774A0 (fi) Ogarvade, biologiskt stabila skinn i fuktig form.
FI900858A0 (fi) Abonnent-telefonanordning.
ATA281288A (de) Vortriebsmaschine u.dgl., insbesondere streckensenkmaschine
FI895879A0 (fi) Pressvals, saerskilt foer pappersmaskiner.
FI901611A0 (fi) Nytt foerfarande foer syntes av n-metyl-3,4-dimetoxifenyletylamin.
BR8805288A (pt) Agentes de acabamento aquosos,processo para sua preparacao.e sua aplicacao
ES1011214Y (es) Horma de geometria variable.
FI894164A0 (fi) I koekskaop, saerskilt i en under diskbordsytan placerad laodor anordbar pappersuppsamlingslaoda.
FI913445A0 (fi) Lyftanordning foer motorfordon, isynnerhet fordonskarosserier.
FI896124A0 (fi) Lyftanordning, speciellt personlyftanordning.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee